Vimta Labs [VIMTALABS] vs Wonder Fibromats [WFL] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Vimta Labs wins in 9 metrics, Wonder Fibromats wins in 8 metrics, with 0 ties. Vimta Labs appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricVimta LabsWonder FibromatsBetter
P/E Ratio (TTM)55.2445.52Wonder Fibromats
Price-to-Book Ratio10.304.22Wonder Fibromats
Debt-to-Equity Ratio2.251.61Wonder Fibromats
PEG Ratio-2.370.64Vimta Labs
EV/EBITDA29.8114.01Wonder Fibromats
Profit Margin (TTM)19.93%8.07%Vimta Labs
Operating Margin (TTM)24.42%3.21%Vimta Labs
EBITDA Margin (TTM)24.42%3.21%Vimta Labs
Return on Equity17.78%59.53%Wonder Fibromats
Return on Assets (TTM)14.43%3.24%Vimta Labs
Free Cash Flow (TTM)$151.19MN/AN/A
Dividend Yield0.83%N/AN/A
1-Year Return158.20%-90.20%Vimta Labs
Price-to-Sales Ratio (TTM)10.620.60Wonder Fibromats
Enterprise Value$38.77B$2.55BVimta Labs
EV/Revenue Ratio10.530.65Wonder Fibromats
Gross Profit Margin (TTM)80.72%9.60%Vimta Labs
Revenue per Share (TTM)$83$293Wonder Fibromats
Earnings per Share (Diluted)$15.88$5.43Vimta Labs
Beta (Stock Volatility)-0.26N/AN/A
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Vimta Labs vs Wonder Fibromats Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Vimta Labs-4.36%28.31%32.10%77.46%67.28%69.69%
Wonder Fibromats-0.83%3.10%-13.45%-24.07%-26.67%-19.82%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Vimta Labs158.20%368.34%1,317.22%2,460.22%4,887.64%761.86%
Wonder Fibromats-90.20%-30.97%191.28%47.42%47.42%47.42%

News Based Sentiment: Vimta Labs vs Wonder Fibromats

Vimta Labs

News based Sentiment: POSITIVE

Vimta Labs reported impressive Q1 FY26 earnings with significant revenue and profit growth, coupled with positive market activity including a bulk purchase and ESOP listing approvals. While analyst opinions vary, the overall trend indicates strengthening investor confidence and growth potential.

View Vimta Labs News Sentiment Analysis

Wonder Fibromats

News based Sentiment: NEGATIVE

The month saw a significant decline in Wonder Fibromats' financial performance, coupled with a company name change. While the initial market reaction was positive, it quickly reversed, indicating underlying concerns about the company's prospects. The high valuation multiples also suggest potential downside risk.

View Wonder Fibromats News Sentiment Analysis

Performance & Financial Health Analysis: Vimta Labs vs Wonder Fibromats

MetricVIMTALABSWFL
Market Information
Market Cap i₹39.13B₹2.36B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i5,221,1311,490
90 Day Avg. Volume i6,158,904497
Last Close₹838.95₹132.68
52 Week Range₹251.52 - ₹902.65₹120.95 - ₹200.00
% from 52W High-7.06%-33.66%
All-Time High₹1,178.00 (Feb 10, 2025)₹1,624.90 (Oct 28, 2024)
% from All-Time High-28.78%-91.83%
Growth Metrics
Quarterly Revenue Growth0.19%0.72%
Quarterly Earnings Growth0.54%-0.11%
Financial Health
Profit Margin (TTM) i0.20%0.08%
Operating Margin (TTM) i0.24%0.03%
Return on Equity (TTM) i0.18%0.60%
Debt to Equity (MRQ) i2.251.61
Cash & Liquidity
Book Value per Share (MRQ)₹85.19₹10.03
Cash per Share (MRQ)₹7.27N/A
Operating Cash Flow (TTM) i₹812.55M₹-162,190,000
Levered Free Cash Flow (TTM) i₹673.42M₹72.77M
Dividends
Last 12-Month Dividend Yield i0.83%N/A
Last 12-Month Dividend i₹4.00N/A

Valuation & Enterprise Metrics Analysis: Vimta Labs vs Wonder Fibromats

MetricVIMTALABSWFL
Price Ratios
P/E Ratio (TTM) i55.2445.52
Forward P/E iN/AN/A
PEG Ratio i-2.370.64
Price to Sales (TTM) i10.620.60
Price to Book (MRQ) i10.304.22
Market Capitalization
Market Capitalization i₹39.13B₹2.36B
Enterprise Value i₹38.77B₹2.55B
Enterprise Value Metrics
Enterprise to Revenue i10.530.65
Enterprise to EBITDA i29.8114.01
Risk & Other Metrics
Beta i-0.26N/A
Book Value per Share (MRQ) i₹85.19₹10.03

Financial Statements Comparison: Vimta Labs vs Wonder Fibromats

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)VIMTALABSWFL
Revenue/Sales i₹975.64MN/A
Cost of Goods Sold i₹188.09MN/A
Gross Profit i₹787.55MN/A
Research & Development iN/AN/A
Operating Income (EBIT) i₹238.28MN/A
EBITDA i₹354.39MN/A
Pre-Tax Income i₹252.62MN/A
Income Tax i₹63.68MN/A
Net Income (Profit) i₹188.94MN/A

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)VIMTALABSWFL
Cash & Equivalents i₹158.36MN/A
Total Current Assets i₹1.88BN/A
Total Current Liabilities i₹643.67MN/A
Long-Term Debt i₹32.24MN/A
Total Shareholders Equity i₹3.79BN/A
Retained Earnings i₹2.80BN/A
Property, Plant & Equipment i₹89.36MN/A

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)VIMTALABSWFL
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricVIMTALABSWFL
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i5,221,1311,490
Average Daily Volume (90 Day) i6,158,904497
Shares Outstanding i44.47M13.40M
Float Shares i14.79MN/A
% Held by Insiders i0.67%N/A
% Held by Institutions i0.03%N/A

Dividend Analysis & Yield Comparison: Vimta Labs vs Wonder Fibromats

MetricVIMTALABSWFL
Last 12-Month Dividend i₹4.00N/A
Last 12-Month Dividend Yield i0.83%N/A
3-Year Avg Annual Dividend i₹2.00N/A
3-Year Avg Dividend Yield i0.44%N/A
3-Year Total Dividends i₹6.00N/A
Ex-Dividend DateMay 30, 2025N/A